Literature DB >> 17308917

Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparations.

Holger F Rabenau1, Branko Marianov, Sabine Wicker, Regina Allwinn.   

Abstract

Measles virus infection as well as measles vaccination induces a long-lasting immune protection. Specific antibodies have been proven to be associated with this immune protection, since measles immunity can be transferred by immune globulin application (passive immunisation). The neutralisation test (NT) is regarded as the gold standard method for measles immunity because it measures functional neutralising antibody, while with the ELISA, which is often based on cell culture grown native virus antigens, predominantly antibodies to the nucleoprotein antigen were detected. To compare the results of NT and ELISA 199 individual sera and 364 gamma globulin samples, which were made from plasma pools, were tested. Qualitative results showed that the sensitivity of the ELISA was 141/144 (97.9%) and specificity was 48/55 (87.3%) when compared to the NT and focused to the patient samples. For the gamma globulin samples the sensitivity and specificity was 100%. As expected no measles NT negative plasma pool samples were found. The present study showed that with increasing NT-titre, the ELISA-values also rise. False negative ELISA results were obtained in 1.5% of patient sera, mainly containing low levels of neutralising antibody. In both antibody tests seropositive specimens revealed a quite good to moderate correlation. Taken together, the measles IgG ELISA is adequately for immunity testing and identifying of seronegative individuals for vaccination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17308917     DOI: 10.1007/s00430-007-0037-2

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  9 in total

1.  Comparison of measles virus-specific antibody titres as measured by enzyme-linked immunosorbent assay and virus neutralisation assay.

Authors:  Susan van den Hof; Arianne B van Gageldonk-Lafeber; Robert S van Binnendijk; Pieter G M van Gageldonk; Guy A M Berbers
Journal:  Vaccine       Date:  2003-10-01       Impact factor: 3.641

2.  [Relevance of sentinel surveillance systems for the implementation and evaluation of vaccination strategies].

Authors:  A Siedler; K Leitmeyer
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2004-12       Impact factor: 1.513

3.  Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay.

Authors:  B J Cohen; R P Parry; D Doblas; D Samuel; L Warrener; N Andrews; D Brown
Journal:  J Virol Methods       Date:  2005-09-26       Impact factor: 2.014

4.  An evaluation of nine commercial EIA kits for the detection of measles specific IgG.

Authors:  L Hesketh; A Charlett; P Farrington; E Miller; T Forsey; P Morgan-Capner
Journal:  J Virol Methods       Date:  1997-06       Impact factor: 2.014

5.  Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status.

Authors:  P W Neumann; J M Weber; A G Jessamine; M V O'Shaughnessy
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

6.  A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody.

Authors:  M S Lee; B Cohen; J Hand; D J Nokes
Journal:  J Virol Methods       Date:  1999-03       Impact factor: 2.014

7.  Evaluation of a new automated microneutralization assay for the quantitative detection of neutralizing antibodies against enteroviruses.

Authors:  H Rabenau; B Weber
Journal:  Zentralbl Bakteriol       Date:  1994-03

8.  Protective titres of measles neutralising antibody.

Authors:  M S Lee; D J Nokes; H M Hsu; C F Lu
Journal:  J Med Virol       Date:  2000-12       Impact factor: 2.327

9.  Comparison of the neutralizing and ELISA antibody titres to human cytomegalovirus (HCMV) in human sera and in gamma globulin preparations.

Authors:  H Schmitz; S Essuman
Journal:  J Med Virol       Date:  1986-10       Impact factor: 2.327

  9 in total
  7 in total

1.  Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity?

Authors:  R Allwinn; B Zeidler; K Steinhagen; E Rohwäder; S Wicker; H F Rabenau; H W Doerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-01       Impact factor: 3.267

2.  Calibration and Evaluation of Quantitative Antibody Titers for Measles Virus by Using the BioPlex 2200.

Authors:  Todd F Hatchette; Heidi Scholz; Shelly Bolotin; Natasha S Crowcroft; Colleen Jackson; Elizabeth McLachlan; Alberto Severini
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

3.  Low titers of measles antibody in mothers whose infants suffered from measles before eligible age for measles vaccination.

Authors:  Hong Zhao; Pei-Shan Lu; Yali Hu; Qiaozhen Wu; Wenhu Yao; Yi-Hua Zhou
Journal:  Virol J       Date:  2010-05-06       Impact factor: 4.099

Review 4.  Passive immunization for the public health control of communicable diseases: current status in four high-income countries and where to next.

Authors:  Megan K Young; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2013-06-19       Impact factor: 3.452

5.  Correlating IgG Levels with Neutralising Antibody Levels to Indicate Clinical Protection in Healthcare Workers at Risk during a Measles Outbreak.

Authors:  Siyuan Hu; Nicola Logan; Sarah Coleman; Cariad Evans; Brian J Willett; Margaret J Hosie
Journal:  Viruses       Date:  2022-08-04       Impact factor: 5.818

6.  Prevalence of measles in vaccinated and non-vaccinated children.

Authors:  Muhammad Asif Zahoor; Muhammad Hidayat Rasool; Muhammad Waseem; Bilal Aslam; Muhammad Kashif Zahoor; Muhammad Saqalein; Zeeshan Nawaz; Rabia Sahar
Journal:  EXCLI J       Date:  2015-04-01       Impact factor: 4.068

7.  ELISA for detection of humoral immunity against measles.

Authors:  Muhammad Asif Zahoor; Muhammad Saqalein; Zeeshan Nawaz
Journal:  EXCLI J       Date:  2015-10-20       Impact factor: 4.068

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.